share_log

NeuBase Therapeutics | 10-QT: Transition report pursuant to Rule 13a-10 or 15d-10 (and amendment thereto)

SEC ·  Jun 6, 2023 04:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more